Monteiro Jade A M, Gama Alexia L H, Oliveira Joao C S, Falcao Matheus V, Melo Ana Karla G, Egypto Danielle C S, Braz Alessandra S
Department of Internal Medicine, Federal University of Paraiba, João Pessoa, Paraiba, 58050-085, Brazil.
Adv Rheumatol. 2024 Dec 18;64(1):90. doi: 10.1186/s42358-024-00432-5.
The prevalence of Fibromyalgia in patients with Systemic Lupus Erythematosus (SLE) is significantly higher compared to the general population. Despite this frequent association, Fibromyalgia remains underdiagnosed and consequently inadequately treated, negatively affecting the quality of life of these patients.
This study aims to evaluate the occurrence of Fibromyalgia and its impact on the quality of life of Brazilian patients with SLE treated at a University Hospital in the state of Paraiba.
This descriptive, observational, and cross-sectional study included patients with SLE diagnosed according to the 2012 criteria of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC). The occurrence of Fibromyalgia was assessed using the American College of Rheumatology (ACR) criteria of 1990 and 2010/2011, revised in 2016. Quality of life was evaluated using the Short-Form 36 (SF-36) questionnaire for all patients, while the Fibromyalgia Impact Questionnaire (FIQ) was applied to those diagnosed with Fibromyalgia.
The sample comprised 107 SLE patients, with an average age of 54.1 years (SD:12.1), of whom 95.4% (102) were women. The prevalence of Fibromyalgia among SLE patients was 19.1% (21), all of whom were women with a mean age of 45.6 years (SD 9.6). The SF-36 scores of SLE patients with Fibromyalgia were consistently lower across all eight domains compared to those without Fibromyalgia, indicating a significant negative impact of this comorbidity.
These findings are consistent with existing literature, highlighting the significant negative impact of Fibromyalgia on the quality of life of patients with SLE.
These findings are consistent with existing literature, highlighting the significant negative impact of Fibromyalgia on the quality of life of patients with SLE.
与普通人群相比，系统性红斑狼疮（SLE）患者中纤维肌痛的患病率显著更高。尽管存在这种常见关联，但纤维肌痛仍未得到充分诊断，因此治疗不足，对这些患者的生活质量产生负面影响。
本研究旨在评估巴西帕拉伊巴州一家大学医院治疗的SLE患者中纤维肌痛的发生率及其对生活质量的影响。
这项描述性、观察性横断面研究纳入了根据2012年系统性红斑狼疮国际协作临床中心（SLICC）标准诊断的SLE患者。使用2016年修订的1990年和2010/2011年美国风湿病学会（ACR）标准评估纤维肌痛的发生情况。对所有患者使用简短健康调查量表（SF - 36）问卷评估生活质量，而纤维肌痛影响问卷（FIQ）则应用于诊断为纤维肌痛的患者。
样本包括107例SLE患者，平均年龄54.1岁（标准差：12.1），其中95.4%（102例）为女性。SLE患者中纤维肌痛的患病率为19.1%（21例），所有患者均为女性，平均年龄45.6岁（标准差9.6）。与无纤维肌痛的SLE患者相比，患有纤维肌痛的SLE患者在所有八个领域的SF - 36评分始终较低，表明这种合并症具有显著的负面影响。
这些发现与现有文献一致，突出了纤维肌痛对SLE患者生活质量的显著负面影响。
这些发现与现有文献一致，突出了纤维肌痛对SLE患者生活质量的显著负面影响。
